Ipratropium Bromide Solution
Product Images NDC 55154-2134

5 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide (NDC 55154-2134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ipratropium 01)

Chemical Structure (Ipratropium 01)
Chemical structure of ipratropium bromide, shown as a molecular diagram including the bromide salt and hydration component.*
FDA Label Image

Figure 1 (Ipratropium 02)

Figure 1 (Ipratropium 02)
An instructional illustration labeled Figure 1, showing hands preparing a small ampule or vial for use by snapping or breaking the top, indicated by the patterned grip area. This image likely demonstrates how to open the ipratropium bromide solution for respiratory inhalation.*
FDA Label Image

Figure 2 (Ipratropium 03)

Figure 2 (Ipratropium 03)
An instructional diagram labeled 'Figure 2' showing how to use a device. It depicts a hand holding the device with arrows indicating a sliding or opening motion on a component, suggesting step-by-step usage guidance for the respiratory inhalation solution.*
FDA Label Image

Figure 3 (Ipratropium 04)

Figure 3 (Ipratropium 04)
An instructional line drawing showing a person using a respiratory inhalation solution device. The illustration depicts the mouth fitting over the inhaler mouthpiece, with an arrow indicating the inhalation direction. This figure is labeled as Figure 3.*
FDA Label Image

0.02% (0.5mg/2.5ml) Bag Label (1a02e20d 3db7 69da E063 6294a90aff4b 00)

0.02% (0.5mg/2.5ml) Bag Label (1a02e20d 3db7 69da E063 6294a90aff4b 00)
Label for Ipratropium Bromide Inhalation Solution 0.02%, 0.5 mg/2.5 mL, in sterile unit-dose vials. The package contains five 2.5 mL vials, each individually sealed in a foil pouch. Manufactured by The Retiedose Corporation and distributed by Cardinal Health 107, LLC. Includes storage instructions and warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.